Intravenous immunoglobulin treatment of lupus nephritis.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Seminars in Arthritis & Rheumatism

• Publication date

  2000-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0049-0172(00)80018-9PMID 10805356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia.

  2010cited by this paper
• Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.

  1998cited by this paper
• Paradoxical and persistent renal impairment in Henoch-Schönlein purpura after high-dose immunoglobulin therapy.

  1997cited by this paper
• Successful treatment of early secondary myelofibrosis in SLE with IVIG

  1997cited by this paper
• [Rheumatoid purpura and intravenous immunoglobulins].

  1997cited by this paper
• Prolonged remission of SLE-associated polyradiculoneuropathy after a single course of intravenous immunoglobulin.

  1996cited by this paper
• New therapeutic avenues in autoimmunity.

  1996cited by this paper
• High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study.

  1996cited by this paper
• Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti‐DNA‐reactive IgG

  1996cited by this paper
• Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis.

  1996cited by this paper
• Purpura rhumatoïde et immunoglobulines intraveineuses

  1996cited by this paper
• Finger Gangrene in an SLE Patient

  1995cited by this paper
• Glomerulonephritis associated with complete deficiency of the fourth component of complement. Response to intravenous immunoglobulin.

  1995cited by this paper
• Treatment of systemic and renal-limited vasculitic disorders with pooled human intravenous immune globulin

  1995cited by this paper
• [Immunologic therapy for glomerulonephritis with combined immunoadsorption and IVIG therapy].

  1995cited by this paper
• Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and end-stage renal disease.

  1995cited by this paper
• Treatment of anti‐neutrophil cytoplasmic antibody (ANCA)‐associated systemic vasculitis with high‐dose intravenous immunoglobulin

  1995cited by this paper
• Acute renal failure associated with immunoglobulin therapy.

  1995cited by this paper
• Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin.

  1995cited by this paper
• Treatment of hemolytic anemia and severe thrombocytopenia with high-dose methylprednisolone and intravenous immunoglobulins in SLE.

  1994cited by this paper
• Long-term i.v. Ig treatment in systemic lupus erythematosus.

  1994cited by this paper
• Acute renal failure after intravenous immunoglobulin therapy.

  1994cited by this paper
• Autoimmune multiorgan involvement in elderly men is it SLE?

  1994cited by this paper
• Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome.

  1994cited by this paper
• Intravenous immunoglobulin-induced osmotic nephrosis.

  1994cited by this paper
• High-Dose Immunoglobulin Therapy for Severe IgA Nephropathy and Henoch-Schonlein Purpura

  1994cited by this paper
• Reversible cardiogenic shock in a patient with lupus myocarditis.

  1993cited by this paper
• The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome.

  1993cited by this paper
• The Effect of Intravenous γ-Globulin on the Induction of Experimental Antiphospholipid Syndrome

  1993cited by this paper
• Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases.

  1993cited by this paper
• Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin.

  1993cited by this paper
• Treatment of antineutrophil cytoplasmic autoantibody-positive systemic vasculitis and glomerulonephritis with pooled intravenous gammaglobulin.

  1992cited by this paper
• Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin.

  1992cited by this paper
• Lupus refractory pleural effusion: transient response to intravenous immunoglobulins.

  1991cited by this paper
• High-dose immunoglobulin therapy in pericarditis caused by SLE.

  1990cited by this paper
• Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins.

  1990cited by this paper
• Recurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus.

  1990cited by this paper
• Use of high-dose intravenous immunoglobulin in systemic lupus erythematosus: report of three cases.

  1989cited by this paper
• Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin.

  1989cited by this paper
• Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization.

  1987cited by this paper
• IgG therapy in systemic lupus erythematosus

  1984cited by this paper

• A Comprehensive and Practical Approach to the Management of Lupus Nephritis in the Current Era.

  2024cites this paper
• Update on available therapies for refractory lupus nephritis

  2023cites this paper
• Expert Perspective: An Approach to Refractory Lupus Nephritis

  2022influential citation
• Efficacy and safety of intravenous immunoglobulin in patients with lupus nephritis: A systematic review of the literature.

  2022cites this paper
• Management of non‐renal manifestations of systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements

  2022cites this paper
• Actualización de las terapias disponibles para la nefritis lúpica refractaria

  2021cites this paper
• Atualização terapêutica no LES juvenil – nefrite

  2021cites this paper
• Kidney disease

  2021cites this paper
• Epilepsy as a Comorbidity in Polymyositis and Dermatomyositis—A Cross-Sectional Study

  2021cites this paper
• Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment

  2021cites this paper
• Refractory lupus nephritis: When, why and how to treat.

  2019cites this paper
• Epidemiology and Management of Lupus Nephritis

  2019cites this paper
• Lupus Nephritis (Including Antiphospholipid Antibody Syndrome), Pediatric

  2019cites this paper
• Use of Intravenous Immunoglobulin Therapy at Unconventional Doses in Refractory Fulminant Systemic Lupus Erythematosus

  2018cites this paper
• Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology

  2018cites this paper
• Intravenous Immunoglobulin: Dermatologic Uses and Mechanisms of Action

  2017cites this paper
• Current status of lupus nephritis

  2017cites this paper
• Inmuno glo bulinas e ndo ve no s as e n las e nfe rme dade s auto inmune s s is té micas

  2016cites this paper
• The Production Processes and Biological Effects of Intravenous Immunoglobulin

  2016cites this paper
• Conventional Treatment of Systemic Lupus Erythematosus

  2016cites this paper
• The role of intravenous immunoglobulins in the treatment of rheumatoid arthritis.

  2015cites this paper
• The multifaceted aspects of refractory lupus nephritis

  2015cites this paper
• Intravenous Immunoglobulin in the Therapeutic Armamentarium of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

  2014cites this paper
• Перспективы применения внутривенного иммуног л обу л ина при аутоиммунных ревматических заболеваниях

  2014cites this paper
• Comparative analysis of NK cell subsets in menstrual and peripheral blood of patients with unexplained recurrent spontaneous abortion and fertile subjects.

  2014cites this paper
• Pragmatic approaches to therapy for systemic lupus erythematosus

  2014cites this paper
• The use of glucocorticoids in systemic lupus erythematosus. After 60 years still more an art than science.

  2013cites this paper
• Successful use of intravenous immunoglobulin in the treatment of resistant lupus nephritis Imunoglobulina intravenosa eficaz no tratamento de nefrite lúpica resistente

  2013cites this paper
• Lupus nephritis: treatment of resistant disease.

  2013cites this paper
• Intravenous Immunoglobulin in the Management of Lupus Nephritis

  2012cites this paper
• Clinical reviews in allergy and immunology

  2012cites this paper
• Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

  2012cites this paper
• Clinical applications of immunoglobulin: update

  2011cites this paper
• Current and novel therapeutics in the treatment of systemic lupus erythematosus.

  2011cites this paper
• The Role of Intravenous Immunoglobulins in the Management of Acute Complex Autoimmune Conditions

  2011cites this paper
• [Indications for intra-venous immunoglobulin treatment in rheumatic diseases].

  2011cites this paper
• Dwived and Sarkar 938 Lupus ephritis and Oxidative Stress

  2010cites this paper
• Lupus ephritis and Oxidative Stress

  2010cites this paper
• The role of high-dose intravenous immunoglobulin in rheumatology.

  2010cites this paper
• Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not!

  2009cites this paper
• HIGH DOSE INTRAVENOUS IMMUNOGLOBULIN FOR SYSTEMIC LUPUS ERYTHEMATOSUS WITH LUPUS NEPHRITIS AND ASSOCIATED STUDIES – CASE REPORT

  2009cites this paper
• Actualidad en el tratamiento de la nefritis lúpica proliferativa

  2009cites this paper
• Palabras clave: nefritis lúpica, agentes citotóxicos, micofenolato mofetil, linfocitos B, rituximab.

  2009cites this paper
• Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature

  2009cites this paper
• Rationale and Strategies for Diagnosis and Management of Lupus Nephritis

  2009cites this paper
• Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.

  2008cites this paper
• Novel therapies of lupus nephritis

  2008cites this paper
• An intravenous immunoglobulin therapy of serious autoimmune rheumatic diseases.

  2008cites this paper
• [Treatment of lupus nephritis].

  2008cites this paper
• Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach.

  2008cites this paper
• Chapter 17 Systemic Lupus Erythematosus: Treatment

  2007cites this paper
• HIGH DOSE INTRAVENOUS IMMUNOGLOBULIN FOR SYSTEMIC LUPUS ERYTHEMATOSUS WITH LUPUSNEPHRITIS AND ASSOCIATED STUDIES ' CASE REPORT

  2007cites this paper
• Efficacy of Various Intravenous Immunoglobulin Therapy Protocols in Autoimmune and Chronic Inflammatory Disorders

  2007cites this paper
• The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases

  2007cites this paper
• Therapeutic options for resistant lupus nephritis.

  2006cites this paper
• [Renal manifestations of systemic autoimmune disease: diagnosis and therapy].

  2006cites this paper
• Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.

  2006cites this paper
• Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders

  2006cites this paper
• Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy

  2006cites this paper
• Nefropatía lúpica. Presentación clínica, clasificación y tratamiento

  2006cites this paper
• High dose intravenous immunoglobulin treatment: Mechanisms of action

  2005cites this paper
• Novel approaches to therapy for systemic lupus erythematosus: update 2005

  2005cites this paper
• Experimental Therapies in Cutaneous Lupus Erythematosus

  2005cites this paper
• Response of Vasculitic Peripheral Neuropathy to Intravenous Immunoglobulin

  2005cites this paper
• Intravenous immunoglobulin therapy and systemic lupus erythematosus

  2005cites this paper
• Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases

  2005cites this paper
• Treatment for lupus nephritis: A revisit

  2005cites this paper
• Anti-DNA idiotypes: from induction of disease to novel therapeutical approaches.

  2005cites this paper
• IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients

  2005cites this paper
• MANAGEMENT OF THERAPY-RESISTANT SYSTEMIC LUPUS ERYTHEMATOSUS WITH RITUXIMAB: REPORT OF A CASE AND REVIEW OF THE LITERATURE

  2005cites this paper
• High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.

  2005cites this paper
• The pros and cons of intravenous immunoglobulin treatment in autoimmune nephropathy.

  2004cites this paper
• 1 – AUTOIMMUNITY AND AUTOIMMUNE DISEASES SUCH AS SYSTEMIC LUPUS ERYTHEMATOSUS

  2004cites this paper
• Manifestations rénales des maladies auto-immunes systémiques : diagnostic et traitement

  2004cites this paper
• Therapy with biologic agents in SLE

  2004cites this paper
• Intravenous immunoglobulin and the kidney--a two-edged sword.

  2004cites this paper
• Renal manifestations of systemic autoimmune disease: diagnosis and therapy.

  2004cites this paper
• IVIG for Autoimmune, Fibrosis, and Malignant Conditions: Our Experience with 200 Patients

  2004cites this paper
• Manifestations rénales des maladies auto-immunes systémiques: diagnostic et traitement

  2004cites this paper
• current state Treatment of severe proliferative lupus nephritis: the

  2003cites this paper
• Rights Annals of the Rheumatic Diseases: the EULAR journal. Copyright © B M J Publishing Group.

  2003cites this paper
• Novel approaches to therapy for SLE

  2003cites this paper
• [Intravenous immunoglobulins in the systemic autoinmune diseases].

  2003cites this paper
• Treatment of severe proliferative lupus nephritis: the current state

  2003cites this paper
• IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy.

  2003cites this paper
• Central nervous system lupus: a clinical approach to therapy

  2003cites this paper
• Inmunoglobulinas endovenosas en las enfermedades autoinmunes sistémicas

  2003cites this paper
• Immunoglobulin for rheumatic diseases in the twenty‐first century: take it or leave it?

  2003cites this paper
• GAMMAGLOBULINA ENDOVENOSA EN EL SÍNDROME NEFRÓTICO. PRESENTACIÓN DE UN PACIENTE.

  2003cites this paper
• Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis

  2003cites this paper
• Clinical utility of intravenous immunoglobulins in autoimmune diseases

  2003cites this paper
• Treatment Options for Juvenile-Onset Systemic Lupus Erythematosus

  2002cites this paper
• Management of lupus erythematosus: recent insights

  2002cites this paper
• New therapies in systemic lupus erythematosus.

  2002cites this paper
• The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases.

  2002cites this paper
• New therapies: plasmapheresis, intravenous immunoglobulin, and monoclonal antibodies.

  2002cites this paper
• Developments in the Immunotherapy of Glomerular Disease

  2002cites this paper
• Intravenous immunoglobulin in neurological disease: a specialist review

  2002cites this paper
• Therapy of systemic lupus erythematosus: a look into the future

  2002cites this paper
• Clinical trials in lupus nephritis

  2001cites this paper